The drug not only cleared the virus from the treated monkeys' blood but also triggered an immune response, helping them develop antibodies while avoiding organ damage.Geisbert explained that while the ...

As well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...

The pill protected 80 per cent of the cynomolgus macaques and 100 per cent of the rhesus macaques, which are biologically ...

Ebola is a severe, often fatal illness with an average death rate of 50%. It spreads between humans through direct contact with an infected person's bodily fluids, including infected blood ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

4. Gaps in scientists’ understanding of how Ebola kills Ebola remains mysterious. It is unbelievably aggressive in the human body, but scientists still don’t understand all the virus’s ...

Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre ...

To address this critical gap in pandemic preparedness, researchers at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center investigated how this deadly virus attaches to ...

First identified in 1976 and thought to have crossed over from bats, Ebola is a deadly viral disease ... which are biologically closer to humans. The drug not only cleared the virus from the ...